1. Home
  2. Philanthropy & Grantmaking
  3. Santa Monica, CA
  4. Prostate Cancer Foundation

Prostate Cancer Foundation

Prostate Cancer Foundation is ranked #6 of 6 philanthropy & grantmaking organizations in Santa Monica, CA, with an America's Best Score of 60 out of 100, based on its 2025 Form 990.

  • Santa Monica, CA
  • Tax-exempt since 1993
  • EIN: 95-4418411
pcf.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
60OF 100 #6 of 6 in Santa Monica ranked philanthropy & grantmaking organizations How this score is calculated

Organization summary

Prostate Cancer Foundation is a 501(c)(3) organization, classified under Philanthropy & Grantmaking (NTEE T20Z). Contributions are tax-deductible.

1250 4Th Street, Santa Monica, CA 90401-1366

Among the 15 scored philanthropy & grantmaking organizations in Santa Monica, Prostate Cancer Foundation holds 9.3 months of operating reserves (peer median 9.3 months), runs a typical yearly surplus of 2.4% (peers: surplus of 0.6%), and has cut spending 0.1% a year (peers: grown spending 11.1% a year).

In fiscal year 2025 it reported $61,798,334 in revenue and $61,308,300 in expenses, with contributions making up 94.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Pcf funds the world's most promising prostate cancer research, turning discoveries into therapies that extend and improve patients' lives. Pcf unites patients, loved ones, researchers, and clinicians in a community focused on ending death and suffering from this disease.

Largest programs · fiscal year 2025

  • The pcf research enterprise is a peer-review research funding program that provides funding to 2,615 scientists conducting innovative research projects at more than 312 leading cancer centers and universities. Priority is given to high-risk, high-return projects with the greatest potential to improve survival and the overall quality of life for men with prostate cancer. The cornerstone of the pcf… Read more

    The pcf research enterprise is a peer-review research funding program that provides funding to 2,615 scientists conducting innovative research projects at more than 312 leading cancer centers and universities. Priority is given to high-risk, high-return projects with the greatest potential to improve survival and the overall quality of life for men with prostate cancer. The cornerstone of the pcf research enterprise in 2025 was our challenge awards program and new tactical awards program, which support cross-disciplinary teams of investigators conducting pioneering research to address critical unmet medical needs for prostate cancer patients. In 2025, pcf funded 13 multi-year team research projects that each offer high potential for improved detection, enhanced quality of life and higher survival rates.

    $27,291,200 spent · 53.5% of program spending
  • For more than 3 million American men and their families fighting prostate cancer and millions more globally, pcf serves as a primary source for new standard-of-care and research information. Pcf educates the public about prostate cancer risks, screening, prevention, treatment options, and side effects. We connect patients, loved ones, care providers, and scientists to critical updates, the latest… Read more

    For more than 3 million American men and their families fighting prostate cancer and millions more globally, pcf serves as a primary source for new standard-of-care and research information. Pcf educates the public about prostate cancer risks, screening, prevention, treatment options, and side effects. We connect patients, loved ones, care providers, and scientists to critical updates, the latest developments, best practices, and news from the treatment pipeline. Since pcf's inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. Pcf aims to spur men and women alike to talk about this disease, to understand its urgency, and to have information-driven hope.

    $17,105,671 spent · 33.5% of program spending
  • Pcf created the young investigator award program with one goal: To build a gifted cohort of human capital supporting the next generation of prostate cancer researchers. Awards are made to early-career scientists working in a research environment capable of supporting high-impact prostate cancer research, drawn from a variety of medical research disciplines. For more than three decades, the pcf pro… Read more

    Pcf created the young investigator award program with one goal: To build a gifted cohort of human capital supporting the next generation of prostate cancer researchers. Awards are made to early-career scientists working in a research environment capable of supporting high-impact prostate cancer research, drawn from a variety of medical research disciplines. For more than three decades, the pcf program has awarded more than $100 million to advance the careers of more than 500 pcf young investigators, ensuring a continued stream of human capital into our research community. The pcf young investigator program plays an integral role in championing, mentoring, and identifying future medical research program leaders.

    $6,005,045 spent · 11.8% of program spending
  • More than 15,000 men cared for by the department of Veterans Affairs (va) hospitals are newly diagnosed with prostate cancer each year, making it the most frequently diagnosed cancer among veterans. The pcf-va partnership is expanding research into prostate cancer precision oncology treatment options. The collaboration is expanding the number of precision oncology clinical studies conducted at vet… Read more

    More than 15,000 men cared for by the department of Veterans Affairs (va) hospitals are newly diagnosed with prostate cancer each year, making it the most frequently diagnosed cancer among veterans. The pcf-va partnership is expanding research into prostate cancer precision oncology treatment options. The collaboration is expanding the number of precision oncology clinical studies conducted at veterans health administration hospitals, ensuring that eligible veterans can access and participate in these studies. The va's precision oncology program for cancer of the prostate (popcap) was established in partnership with the Prostate Cancer Foundation 2016. The program uses genetic testing to find the best possible treatments for veterans with advanced prostate cancer. Popcap's network extends across the U.S. It includes 21 precision oncology centers of excellence, supplemented by regional centers, that provide cancer care to any veteran who develops prostate cancer, no matter where he lives.

    $600,000 spent · 1.2% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 83¢ went to programs, 9¢ to management and 8¢ to fundraising.

  • Programs $51,001,916
  • Management $5,648,005
  • Fundraising $4,658,379

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score60 / 100
Rank in Santa Monica#6 of 6
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves9.3 mo; 17.1 mo in cash6.5 / 25
Financial balance (median margin)+2.4%15.7 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−0.1% / yr7.5 / 15
Track record33 years10 / 10
Debt load57.7% of assets0.5 / 10
Total60.1 → 60
Spending on programs
Not scored; America's Best needs 65%+
83%Meets

Compared with Santa Monica peers

MeasureThis organizationPeer median
Operating reserves9.3 mo9.3 mo
Typical margin+2.4%+0.6%
Spending growth−0.1% / yr+11.1% / yr
Debt load57.7%7.8%

Peers: the 15 Santa Monica philanthropy & grantmaking organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$61,798,334Fiscal year 20252022: $71,921,85120222023: $57,291,09520232024: $56,686,21520242025: $61,798,3342025
Expenses$61,308,300Fiscal year 20252022: $61,472,06820222023: $55,134,76320232024: $58,177,91920242025: $61,308,3002025
Total assets$112,119,968Fiscal year 20252022: $87,285,83620222023: $91,770,97820232024: $105,767,42420242025: $112,119,9682025
Total liabilities$64,690,480Fiscal year 20252022: $41,910,19520222023: $43,788,55320232024: $59,314,10720242025: $64,690,4802025
Fiscal year ending December 2025
Revenue$61,798,334
Expenses$61,308,300
Net income$490,034
Net assets$47,429,488

Notable sources of revenue

Percent of total revenue
Contributions$58,409,722
Program services$2,210
Investment income$3,386,402
Other (net)$0

Assets / debt

Total assets$112,119,968
Total liabilities$64,690,480
Net assets$47,429,488

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$56,686,215
Expenses$58,177,919
Net income−$1,491,704
Net assets$46,453,317

Notable sources of revenue

Percent of total revenue
Contributions$54,024,868
Program services$2,687
Investment income$2,658,660
Other (net)$0

Assets / debt

Total assets$105,767,424
Total liabilities$59,314,107
Net assets$46,453,317

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$57,291,095
Expenses$55,134,763
Net income$2,156,332
Net assets$47,982,425

Notable sources of revenue

Percent of total revenue
Contributions$54,887,913
Program services$4,555
Investment income$2,398,627
Other (net)$0

Assets / debt

Total assets$91,770,978
Total liabilities$43,788,553
Net assets$47,982,425

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$71,921,851
Expenses$61,472,068
Net income$10,449,783
Net assets$45,375,641

Notable sources of revenue

Percent of total revenue
Contributions$71,390,051
Program services$4,752
Investment income$526,555
Other (net)$493

Assets / debt

Total assets$87,285,836
Total liabilities$41,910,195
Net assets$45,375,641

Compensation

Officers and key employees$2,498,856
Share of expenses4.1%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?